Identification of potential protein quality markers in pathogen inactivated and gamma-irradiated red cell concentrates

Proteomics - Clinical Applications

Volumn 11, Issue 7-8, 2017, Pages

  Chen, Deborah ^a   Schubert, Peter ^a,b   Devine, Dana V ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

Author keywords

Gamma irradiation; Hemolysis; iTRAQ; Pathogen inactivation technology; Red blood cells; Transfusion medicine

Indexed keywords

ACTIN; CATALASE; HEMOGLOBIN; MEMBRANE PROTEIN; PEROXIREDOXIN 2; PROTEASOME; SPECTRIN; STOMATIN; BIOLOGICAL MARKER;

ARTICLE; BLOOD SAFETY; BLOOD STORAGE; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE GHOST; GAMMA IRRADIATION; HEMATOLOGICAL PROCEDURE; HEMOLYSIS; HUMAN; IMMUNOBLOTTING; POSTCOLLECTION MANIPULATION; PRIORITY JOURNAL; PROTEOMICS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; ERYTHROCYTE; GAMMA RADIATION; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; RADIATION RESPONSE; SAFETY; SPECIMEN HANDLING;

BIOMARKERS; ERYTHROCYTES; GAMMA RAYS; HUMANS; MEMBRANE PROTEINS; MICROBIAL VIABILITY; PROTEOMICS; SAFETY; SPECIMEN HANDLING;

EID: 85013054763     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201600121     Document Type: Article

References (55)

1. Sparrow, R. L., Time to revisit red blood cell additive solutions and storage conditions: a role for "omics" analyses. Blood Transfus. 2012, 10(Suppl 2), s7–11.
2. Anderson, K. C., Weinstein, H. J., Transfusion-associated graft-versus-host disease. N. Engl. J. Med. 1990, 323, 315–321.
3. Treleaven, J., Gennery, A., Marsh, J., Norfolk, D. et al., Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. Br. J. Haematol. 2011, 152, 35–51.
4. Salunkhe, V., van der Meer, P. F., de Korte, D., Seghatchian, J. et al., Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demands. Transfus. Apher. Sci. 2015, 52, 19–34.
5. Pelszynski, M. M., Moroff, G., Luban, N. L., Taylor, B. J. et al., Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 1994, 83, 1683–1689.
6. Xu, D., Peng, M., Zhang, Z., Dong, G. et al., Study of damage to red blood cells exposed to different doses of γ-ray irradiation. Blood Transfus. 2012, 10, 321–330.
7. Leitner, G. C., Neuhauser, M., Weigel, G., Kurze, S. et al., Altered intracellular purine nucleotides in gamma-irradiated red blood cell concentrates. Vox Sang. 2001, 81, 113–118.
8. Anand, A. J., Dzik, W. H., Imam, A., Sadrzadeh, S. M., Radiation-induced red cell damage: role of reactive oxygen species. Transfusion 1997, 37, 160–165.
9. Moreira, O. C., Oliveira, V. H., Benedicto, L. B., Nogueira, C. M. et al., Effects of gamma-irradiation on the membrane ATPases of human erythrocytes from transfusional blood concentrates. Ann. Hematol. 2008, 87, 113–119.
10. Serrano, K., Chen, D., Hansen, A. L., Levin, E. et al., The effect of timing of gamma-irradiation on hemolysis and potassium release in leukoreduced red cell concentrates stored in SAGM. Vox Sang. 2014, 106, 379–381.
11. Katharia, R., Chaudhary, R., Agarwal, P., Prestorage gamma irradiation induces oxidative injury to red cells. Transfus Apher. Sci. 2013, 48, 39–43.
12. Goodrich, R. P., Doane, S., Reddy, H. L., Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals 2010, 38, 20–30.
13. Reddy, H. L., Doane, S. K., Keil, S. D., Marschner, S. et al., Development of a riboflavin and ultraviolet light-based device to treat whole blood. Transfusion 2013, 53(Suppl 1), 131S–136S.
14. Fast, L. D., Nevola, M., Tavares, J., Reddy, H. L. et al., Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? Transfusion 2013, 53, 373–381.
15. Schubert, P., Culibrk, B., Karwal, S., Serrano, K. et al., Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method. Transfusion 2015, 55, 815–823.
16. Hansen, A. L., Kurach, J. D., Turner, T. R., Jenkins, C. et al., The effect of processing method on the in vitro characteristics of red blood cell products. Vox Sang. 2015, 108, 350–358.
17. FDA, Guidance for Industry. Gamma irradiation of blood and blood components: a pilot program for licensing. Food and Drug Administration 2000.
18. de Korte, D., Kleine, M., Korsten, H. G., Verhoeven, A. J., Prolonged maintenance of 2,3-diphosphoglycerate acid and adenosine triphosphate in red blood cells during storage. Transfusion 2008, 48, 1081–1089.
19. Crescentini, G., Stocchi, V., Fast reversed-phase high-performance liquid chromatographic determination of nucleotides in red blood cells. J. Chromatogr. 1984, 290, 393–399.
20. Harboe, M., A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry. Scand. J. Clin. Lab. Invest. 1959, 11, 66–70.
21. Usry, R. T., Moore, G. L., Manalo, F. W., Morphology of stored, rejuvenated human erythrocytes. Vox Sang. 1975, 28, 176–183.
22. Dodge, J. T., Mitchell, C., Hanahan, D. J., The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem. Biophys. 1963, 100, 119–130.
23. Rappsilber, J., Ishihama, Y., Mann, M., Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 2003, 75, 663–670.
24. Tabb, D. L., Vega-Montoto, L., Rudnick, P. A., Variyath, A. M. et al, Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. J. Proteome Res. 2010, 9, 761–776.
25. Schubert, P., Culibrk, B., Karwal, S., Goodrich, R. P. et al., Protein translation occurs in platelet concentrates despite riboflavin/UV light pathogen inactivation treatment. Proteomics Clin. Appl. 2016, 10, 839–850.
26. Jordan, A., Chen, D., Yi, Q. L., Kanias, T. et al., Assessing the influence of component processing and donor characteristics on quality of red cell concentrates using quality control data. Vox Sang. 2016, 111, 8–15.
27. Hess, J. R., Sparrow, R. L., van der Meer, P. F., Acker, J. P. et al., Red blood cell hemolysis during blood bank storage: using national quality management data to answer basic scientific questions. Transfusion 2009, 49, 2599–2603.
28. Sowemimo-Coker, S. O., Red blood cell hemolysis during processing. Transfus. Med. Rev. 2002, 16, 46–60.
29. Antonelou, M. H., Kriebardis, A. G., Stamoulis, K. E., Economou-Petersen, E. et al., Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-adenine-glucose-mannitol. Transfusion 2010, 50, 376–389.
30. Qadri, S., Chen, D., Schubert, P., Devine, D. V. et al., Pathogen inactivation by riboflavin and ultraviolet light illumination accelerates the red blood cell storage lesion and promotes eryptosis. Transfusion 2016; accepted. doi: 10.1111/trf.13959.
31. Boilard, E., Duchez, A. C., Brisson, A., The diversity of platelet microparticles, Curr. Opin. Hematol. 2015, 22, 437–444.
32. Poncelet, P., Robert, S., Bailly, N., Garnache-Ottou, F. et al., Tips and tricks for flow cytometry-based analysis and counting of microparticles, Transfus. Apher. Sci. 2015, 53, 110–126.
33. Wolfe, L. C., Oxidative injuries to the red cell membrane during conventional blood preservation. Semin. Hematol. 1989, 26, 307–312.
34. Chiu, D., Kuypers, F., Lubin, B., Lipid peroxidation in human red cells. Semin. Hematol. 1989, 26, 257–276.
35. Hebbel, R. P., Leung, A., Mohandas, N., Oxidation-induced changes in microrheologic properties of the red blood cell membrane. Blood 1990, 76, 1015–1020.
36. Kriebardis, A. G., Antonelou, M. H., Stamoulis, K. E., Economou-Petersen, E. et al., Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells. J. Cell. Mol. Med. 2007, 11, 148–155.
37. Kim, Y. K., Kwon, E. H., Kim, D. H., Won, D. I. et al., Susceptibility of oxidative stress on red blood cells exposed to gamma rays: hemorheological evaluation. Clin. Hemorheol. Microcirc. 2008, 40, 315–324.
38. Zolla, L., D'Alessandro, A., An efficient apparatus for rapid deoxygenation of erythrocyte concentrates for alternative banking strategies. J. Blood Transfus. 2013, 2013, Article ID 896537, 8 pages. doi: 10.1155/2013/896537
39. Yoshida, T., AuBuchon, J. P., Dumont, L. J., Gorham, J. D. et al., The effects of additive solution pH and metabolic rejuvenation on anaerobic storage of red cells. Transfusion 2008, 48, 2096–2105.
40. Pallotta, V., Gevi, F., D'alessandro, A., Zolla, L., Storing red blood cells with vitamin C and N-acetylcysteine prevents oxidative stress-related lesions: a metabolomics overview. Blood Transfus. 2014, 12, 376–387.
41. Arun, P., Padmakumaran Nair, K. G., Manojkumar, V., Deepadevi, K. V. et al., Decreased hemolysis and lipid peroxidation in blood during storage in the presence of nicotinic acid. Vox Sang. 1999, 76, 220–225.
42. Pasini, E. M., Kirkegaard, M., Mortensen, P., Lutz, H. U. et al., In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 2006, 108, 791–801.
43. Bosman, G. J., Lasonder, E., Luten, M., Roerdinkholder-Stoelwinder, B. et al., The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008, 48, 827–835.
44. D'Alessandro, A., D'Amici, G. M., Vaglio, S., Zolla, L., Time-course investigation of SAGM-stored leukocyte-filtered red bood cell concentrates: from metabolism to proteomics. Haematologica 2012, 97, 107–115.
45. Longo, V., Marrocco, C., Zolla, L., Rinalducci, S., Label-free quantitation of phosphopeptide changes in erythrocyte membranes: towards molecular mechanisms underlying deformability alterations in stored red blood cells. Haematologica 2014, 99, e122–125.
46. Rinalducci, S., D'Amici, G. M., Blasi, B., Vaglio, S. et al., Peroxiredoxin-2 as a candidate biomarker to test oxidative stress levels of stored red blood cells under blood bank conditions. Transfusion 2011, 51, 1439–1449.
47. Fujino, T., Watanabe, K., Beppu, M., Kikugawa, K. et al., Identification of oxidized protein hydrolase of human erythrocytes as acylpeptide hydrolase. Biochim. Biophys. Acta 2000, 1478, 102–112.
48. De Palma, A., Roveri, A., Zaccarin, M., Benazzi, L. et al., Extraction methods of red blood cell membrane proteins for Multidimensional Protein Identification Technology (MudPIT) analysis. J. Chromatogr. A 2010, 1217, 5328–5336.
49. Low, T. Y., Seow, T. K., Chung, M. C., Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2002, 2, 1229–1239.
50. Davies, K. J., Degradation of oxidized proteins by the 20S proteasome. Biochimie 2001, 83, 301–310.
51. Schubert, P., Culibrk, B., Serrano, K., Levin, E. et al., Improvement of red cell quality upon pathogen inactivation of whole blood using riboflavin/UV light by deoxygenation. Transfusion 2016, 56, SP42.
52. Lee, T. H., Kim, S. U., Yu, S. L., Kim, S. H. et al., Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 2003, 101, 5033–5038.
53. Johnson, R. M., Ho, Y. S., Yu, D. Y., Kuypers, F. A. et al., The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism. Free Radic. Biol. Med. 2010, 48, 519–525.
54. Tzounakas, V. L., Kriebardis, A. G., Papassideri, I. S., Antonelou, M. H., Donor-variation effect on red blood cell storage lesion: a close relationship emerges. Proteomics Clin. Appl. 2016, 10, 791–804.
55. Mueller, S., Riedel, H. D., Stremmel, W., Direct evidence for catalase as the predominant H2O2 -removing enzyme in human erythrocytes. Blood 1997, 90, 4973–4978.